Zobrazeno 1 - 10
of 36
pro vyhledávání: '"YUTA SAWATANI"'
Autor:
Toshiki Hyodo, Nobuyuki Kuribayashi, Chonji Fukumoto, Yuske Komiyama, Ryo Shiraishi, Ryouta Kamimura, Yuta Sawatani, Erika Yaguchi, Tomonori Hasegawa, Sayaka Izumi, Takahiro Wakui, Koh-ichi Nakashiro, Daisuke Uchida, Hitoshi Kawamata
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Mutations in p53 are common in human oral squamous cell carcinoma (OSCC). However, in previous analyses, only detection of mutant p53 protein using immunohistochemistry or mutations in some exons have been examined. Full length mutant p53 pr
Externí odkaz:
https://doaj.org/article/c3273cc919d246c78c8e65a976e85db2
Publikováno v:
BMC Oral Health, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background The present study examined the effectiveness of high-purity macro/microporous beta-tricalcium phosphate (HPMM β-TCP) as a bone grafting material for maxillary sinus floor elevation by morphometric, histopathological, and histomor
Externí odkaz:
https://doaj.org/article/e043188468d1487c90c4b771a6103831
Autor:
Chonji Fukumoto, Shouhei Ogisawa, Masashi Tani, Toshiki Hyodo, Ryouta Kamimura, Yuta Sawatani, Tomonori Hasegawa, Yuske Komiyama, Atsushi Fujita, Takahiro Wakui, Yasuo Haruyama, Gen Kobashi, Hitoshi Kawamata
Publikováno v:
BMC Geriatrics, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background The status of oral cancer therapy in elderly patients in Japan, where ageing is rapidly progressing, may serve as a model for other countries with similar demographics. There is controversy over what kind of treatment should be ap
Externí odkaz:
https://doaj.org/article/2adb1d5acb574aa8b9cd1dc54e943378
Autor:
Chonji Fukumoto, Ryo Oshima, Yuta Sawatani, Ryo Shiraishi, Toshiki Hyodo, Ryouta Kamimura, Tomonori Hasegawa, Yuske Komiyama, Sayaka Izumi, Atsushi Fujita, Takahiro Wakui, Hitoshi Kawamata
Publikováno v:
Cancers, Vol 13, Iss 22, p 5843 (2021)
Background: The surveillance methods oral squamous cell carcinoma (OSCC) patients may be chosen by considering the risk for recurrence, and it is important to establish appropriate methods during the period in which latent/dormant cancer cells become
Externí odkaz:
https://doaj.org/article/4da3c54da4f94464b655713c6639c0e4
Autor:
Ryouta Kamimura, Daisuke Uchida, Shin-ichiro Kanno, Ryo Shiraishi, Toshiki Hyodo, Yuta Sawatani, Michiko Shimura, Tomonori Hasegawa, Maki Tsubura-Okubo, Erika Yaguchi, Yuske Komiyama, Chonji Fukumoto, Sayaka Izumi, Atsushi Fujita, Takahiro Wakui, Hitoshi Kawamata
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 20, p 10913 (2021)
TSC-22 (TGF-β stimulated clone-22) has been reported to induce differentiation, growth inhibition, and apoptosis in various cells. TSC-22 is a member of a family in which many proteins are produced from four different family genes. TSC-22 (correspon
Externí odkaz:
https://doaj.org/article/8c8151a8504c4f5c9762369fc826c3c7
Autor:
Sayaka Izumi, Yuske Komiyama, Michiko Shimura, Yuta Sawatani, Ryo Oshima, Mamabu Zama, Chonji Fukumoto, Ryouta Kamimura, Erika Yaguchi, Takahiro Wakui, Koh-ichi Nakashiro, Daisuke Uchida, Hitoshi Kawamata
Publikováno v:
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 34:359-363
Autor:
Toshiki , Hyodo, Chonji , Fukumoto, Yuta, Sawatani, Ryouta , Kamimura, Ryo, Oshima, Tomonori , Hasegawa, Sayaka , Izumi, Atsushi, Fujita, Takahiro, Wakui, Hitoshi, Kawamata
Publikováno v:
Dokkyo Journal of Medical Sciences. 48(3):211-218
薬剤関連顎骨壊死(以下,MRONJ)の治療では積極的に外科療法を推奨する報告が多くみられる一方,保存療法に関して有効性や治療成績を示した報告は少ない.われわれはMRONJ治療の現状
Autor:
Yuta Sawatani, Yuske Komiyama, Koh-ichi Nakashiro, Daisuke Uchida, Chonji Fukumoto, Michiko Shimura, Tomonori Hasegawa, Ryouta Kamimura, Masayo Hitomi-Koide, Toshiki Hyodo, Hitoshi Kawamata
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 17, p 6292 (2020)
Administration of cetuximab (C-mab) in combination with paclitaxel (PTX) has been used for patients with head and neck squamous cell carcinoma (SCC) clinically. In this study, we attempted to clarify the molecular mechanisms of the enhancing anticanc
Externí odkaz:
https://doaj.org/article/9aa895be0ca04626be704e3e5eba7e04
Autor:
Toshiki Hyodo, Nobuyuki Kuribayashi, Chonji Fukumoto, Yuske Komiyama, Ryo Shiraishi, Ryouta Kamimura, Yuta Sawatani, Erika Yaguchi, Tomonori Hasegawa, Sayaka Izumi, Takahiro Wakui, Koh-ichi Nakashiro, Daisuke Uchida, Hitoshi Kawamata
Mutations in p53 are common in human oral squamous cell carcinoma (OSCC). However, in previous analyses, only detection of mutant p53 protein using immunohistochemistry or mutations in some exons have been examined. Full length mutant p53 protein in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09f9ac0876fb9b36b04f59756992d97f
https://doi.org/10.21203/rs.3.rs-1851167/v1
https://doi.org/10.21203/rs.3.rs-1851167/v1
Autor:
Atsushi Fujita, Yuske Komiyama, Takahiro Wakui, Tomonori Hasegawa, Manabu Zama, Chonji Fukumoto, Yuta Sawatani, Ryo Shiraishi, Michiko Shimura, Hitoshi Kawamata
Publikováno v:
Investigational New Drugs
SummaryA retrospective cohort study was performed to investigate the effectiveness of preemptive postsurgical therapy with cetuximab for patients with a major risk of recurrence or metastasis after clinical complete resection of primary oral squamous